Justine Boles

Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa

Nicholas I. Paton, Cissy Kityo, Anne Hoppé et al. · New England Journal of Medicine · 2014 · 205 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

James Hakim, Cissy Kityo, Anne Hoppé et al. · The Lancet Infectious Diseases · 2017 · 41 citations · Full text

Pharmacy, Infectious Disease Control, Pharmacotherapy +17

A Sunscreen's Labeled Sun Protection Factor May Overestimate Protection at Temperate Latitudes: A Human In Vivo Study

Antony R. Young, Justine Boles, Bernd Herzog et al. · Journal of Investigative Dermatology · 2010 · 40 citations · Full text

Public Health, Dermatology, Preventive Medicine +10

Palliative long-term abdominal drains versus repeated drainage in individuals with untreatable ascites due to advanced cirrhosis: study protocol for a feasibility randomised controlled trial

Lucia Macken, Louise Mason, Catherine Evans et al. · Trials · 2018 · 20 citations · Full text

Medicine, Internal Medicine, Surgery +17

Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial

Cissy Kityo, David Dunn, Anne Hoppé et al. · Clinical Infectious Diseases · 2018 · 12 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17